ADVATE
TAK-761-4009
Approved mab completed
Quick answer
ADVATE for Hemophilia A is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hemophilia A
- Phase
- Approved
- Modality
- mab
- Status
- completed